Latest News

  • 20 May 2015

    TapImmune to Present Clinical & Scientific Update at th...

    SEATTLE, May 20, 2015 /PRNewswire/ — TapImmune (TPIV), a clinic stage Cancer Immunotherapy Company, announced today that Dr. Glynn Wilson will present at the 2015 Marcum MicroCap Conference held Wednesday, May 27, 2015 and Thursday, May 28, 2015, at the Grand Hyatt New York. The...

    more >

  • 15 May 2015

    Phase I Study in Ovarian & Breast Cancer Published in A...

    SEATTLE, Wash., May 15, 2015 /PRNewswire/ – TapImmune, Inc. (TPIV),  is pleased to announce that an Abstract on a Phase I Study on the Safety and Immunogenicity of a folate receptor alpha (FRAα) peptide vaccine has been published in J Clin. Oncol., 33:5s, 2015 (suppl; abstr e14028) which,...

    more >